Hints and tips:
...The pain is only starting to set in....
...That spring it raised about $2bn from investors, including in the Middle East and Asia, who had attributed the drawdown to growing pains....
...Employees have a “Pain Button” app they can use to signal their emotions at any given time; a “Dot Collector” that allows users to rate one another continuously on a grid system; and “Baseball Cards” that...
...Chefs and restaurateurs in “the city that never sleeps” are feeling the pain following a government-ordered ban to close bars and restaurants in a desperate bid to stem the spread of the virus....
...The promise is instead merely that it will provide superior risk-adjusted performance on average across market conditions in exchange for suffering pain in some market conditions.”...
...Companies in other specialist search markets have already been lining up to push their cases....
...Others in the medical establishment, including some pain specialists and most drug makers, say the solution is not necessarily fewer drugs but better ones — a new generation of opioids with physical or chemical...
...Should the deal for Bausch & Lomb get done, it would mark the most ambitious acquisition yet for Valeant, the specialist pharmaceutical business that has become a serial purchaser of rivals over the past...
...All this pain is justified, for reasons that go deeper than the financial crisis....
...A part of Better Place’s growing pains comes down to consumers’ scepticism towards electric cars, which are selling in smaller numbers even more than pessimistic industry forecasters had predicted....
...“We feel your pain.”...
...Analysts say the limited ability to raise funds suggests that further debt restructurings, causing pain to domestic and international lenders, are likely....
...ApaTech, a synthetic bone specialist spun out of London’s Queen Mary University, on Monday agreed to be acquired by Baxter International, which is paying $240m up front plus a further $90m related to hitting...
...The company is a minority-owned partnership between RLJ Companies LLC – owned by Robert L....
...Hamilton-based Celtic Pharma has just flipped the first product in its portfolio, licensing to Alpharma of the US the rights to its lead product Diractin, for the treatment of deep pain....
International Edition